Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Supplier: Sterile Medical Fluids (Irrigation Water)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires the supply of sterile water for irrigation, USP, in 1000 mL sterile containers, each packaged in cases containing 12 units. All products must fully comply with FDA and United States Pharmacopeia standards, including proper labeling and adherence to hazard communication requirements. The product is intended for medical use and must meet stringent purity and sterility specifications to ensure patient safety. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, and the requirement is structured as a subcontract within the Department of Defense’s Medical Supply Chain Pharm FSA procurement framework. The offer must be submitted by the response deadline of August 10, 2026, with the contract originating from a solicitation posted on August 3, 2026. Place of performance is designated as FPO with ZIP code 96671, indicating delivery to a military post office location. The contract falls under the jurisdiction of the Department of Defense and is managed through the DIBBS procurement portal, where full solicitation details can be accessed via the provided link. No set-aside designation is specified, and the contract is open to qualified suppliers capable of consistently delivering sterile medical fluids that meet federal regulatory benchmarks.

General Info

Supply sterile water for irrigation, USP, 1000 mL units, FDA/USP compliant, to FPO 96671 by August 10, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AP, 96671, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of sterile water for irrigation, USP, in 1000 mL sterile containers, packaged in cases of 12 units, compliant with FDA USP standards, labeling, and hazard communication requirements.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
GABAPENTIN CAPSULES
Solicitation # SPE2DP-26-T-4457
GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4452
The contract pertains to the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of 19 business units (BT), where one BT equals 45 grams, under solicitation number SPE2DP-26-T-4452. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months, and delivery is required within five days of order placement to destinations including Offutt Air Force Base, Fort Hood, and Dyess Air Force Base, under FOB Destination terms, meaning the contractor bears all transportation risks and costs until delivery. Packaging and marking must strictly comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation, packing, and storage must adhere to MIL-STD-2073-1E, with supplemental requirements IP025 applying to hazardous materials. All units must be sealed in commercial containers that protect against damage, and exterior shipping containers must ensure safe delivery at the lowest carrier rate. The product must be marked in accordance with MMS No. 1, and copies are available through DLA Troop Support or online. The contract involves fixed-price line items totaling $131.60, with a zero variance allowance on quantity, and inspection and acceptance occur at the delivery point. Invoicing is required through Wide Area WorkFlow (WAWF), and compliance with safeguarding covered defense information as per NIST SP 800-171 and DFARS clauses is mandatory. The contractor must provide a Unique Entity Identifier (UEI) and CAGE code, and represent their small business status under applicable categories. Specific clause requirements include combatting trafficking in persons, employment eligibility verification, sustainable products, hazardous material identification, and prohibitions on hexavalent chromium and toxic material storage. The solicitation was issued on August 3, 2026, with responses due by August 10, 2026, and submissions are exclusively through the DLA Internet Bid Board System (DIBBS). The procuring agency is the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, with Imerah Burnett as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
LIDOCAINE HYDROCHLORID
Solicitation # SPE2DP-26-T-4454
Lidocaine hydrochloride and dextrose injection in 500 mL premixed bags, containing 0.4% lidocaine and 5% dextrose, is being procured under solicitation SPE2DP-26-T-4454 with a unit of issue defined as a package of 18 bags. The item must meet stringent technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, and packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. At least 16 months of shelf life must remain at the time of delivery to the first government activity, as the product has a fixed 18-month non-extendable shelf life under Type I (Code K) requirements. The drug is regulated by the FDA, and contractors must ensure full compliance with all applicable federal standards for commercial packaging, including ASTM D3951 where applicable, though DLA requirements take precedence. The product is currently in limited supply due to manufacturing constraints, and only Baxter Healthcare Corp’s specific NDC 00338-0409-03 and part number 2B0973P are authorized. Delivery is required within five days of award, FOB destination, with zero variance permitted in quantity. The shipment must be sent via traceable and expedited means to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632, using RDD 777 and VSM logistics protocols, and parcel post is strictly prohibited. Packaging must be palletized according to RP001 requirements and labeled in full compliance with DLA’s medical marking standards. The contract specifies a single purchase request quantity of one package, with a required delivery date of August 5, 2026, and procurement is managed by the Department of Defense’s Medical Supply Chain PHARM FSA. All bidders must provide detailed manufacturer and product information for FDA verification through EBS referral prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE IRRIGA
Solicitation # SPE2DP-26-T-4449
Sodium Chloride Irrigation, USP, is prescribed as a 0.9% solution in 250 mL plastic squeeze bottles, packaged 24 bottles per packing group, and must be stored at controlled room temperature of 25 degrees Celsius with protection from excessive heat. The product must comply with the DLA Master List of Technical and Quality Requirements, and its shelf life is fixed at 36 months without extension, classified as a Type I (Code Q) item. All packaging and labeling must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, with documentation available via DLA Troop Support. Each unit must be sealed and protected from damage, and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to the designated destination. The item is identified by NSN 6505-01-253-8150 and NDC 00338-0048-02, supplied by Baxter Healthcare Corp, and is subject to a firm fixed price with zero variance allowed in quantity. Delivery is required FOB destination within five days of contract award, with inspection and acceptance occurring at the point of delivery. The contract is issued under solicitation SPE2DP-26-T-4449, with a response deadline of August 10, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. All data, including point of contact James Foggie and delivery location at Fort Bragg, NC, is governed by Federal procurement standards under the Department of Defense.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4282
The contract solicitation SPE2DP-26-T-4282 seeks the procurement of TOLNAFTATE POWDER, USP 1%, in 45 gram units, with a total quantity of 93 BT (where 1 BT equals 45 grams), for delivery to multiple military locations including Fort Bragg, NC, and Mountain Home AFB, ID. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months and must be packaged and marked in strict accordance with Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129. Packaging must comply with MIL-STD-2073-1E, ensuring each unit is sealed in a protective container and shipped in commercial exterior containers suitable for safe, cost-effective transport via common carriers to the designated destination. The contract mandates FOB destination delivery, inspection and acceptance at the point of delivery, and electronic invoicing through Wide Area WorkFlow (WAWF). All materials must adhere to Hazard Communication Standard (29 CFR 1910.1200) for labeling hazardous substances and must be free of covered defense telecommunications equipment as prohibited under clause 252.204-7018. The solicitation includes mandatory FAR and DFARS clauses covering cybersecurity (252.204-7012), safeguarding covered defense information, whistleblower protections, post-employment restrictions, and small business representations. Although unit pricing is not specified, the solicitation is issued under simplified acquisition procedures and contemplates a fixed-price contract, with award subject to socioeconomic set-aside programs including 8(a), HUBZone, WOSB, and SDVOSB. The offeror must maintain a valid Unique Entity ID and submit proposals electronically through DIBBS by the stated deadline, with compliance to DLA Master Solicitation Revision 105 governing non-specified terms and conditions.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 2 days
View Details
NAICS: 325412
New
DIBBS
BENZONATATE CAPSULES
Solicitation # SPE2DP-26-T-4467
BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product is regulated by the FDA and must be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), protected from light, moisture, and humidity. It has a non-extendable shelf life of 36 months and must be marked in compliance with the latest Medical Marking Standard No. 1. Packaging must adhere to DLA’s RP001 requirements, MIL-STD-129 labeling standards, and either ASTM D3951 for non-hazardous items or TQ requirement IP025 if classified as hazardous under FED-STD-313. The unit of issue is a bottle (BT), and palletization must conform to DLA procurement standards. The item is identified by NSN 6505006601798 and has approved manufacturers including AVKARE LLC, GOLDEN STATE MEDICAL SUPPLY, INC., and PROFICIENT RX LP, each with their respective NDC numbers. This contract, issued under solicitation SPE2DP-26-T-4467, calls for two bottles to be delivered FOB destination within 10 days of award, with strict zero variance tolerance on quantity. Delivery is required to the U.S. military facility at Smith Barracks in Baumholder, Germany, with specified transportation and marking instructions governed by DLA procedural notes C19 and C20. The contract specifies the original required delivery date as August 5, 2026, and includes technical and quality requirements referenced from the DLA Master List, which take precedence over general commercial standards. The procurement is a federal acquisition under NAICS code 325412, with primary point of contact Imerah Burnett at the Department of Defense’s Medical Supply Chain PHARM FSA. All supplies must be marked with government identification only after acceptance, per RQ011, and the contracting official must submit an electronic referral in EBS prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
BISMUTH SUBSALICYLA
Solicitation # SPE2DP-26-T-4459
The contract pertains to the procurement of Bismuth Subsalicylate Suspension, 262 mg per 15 mL, in 240 mL bottles, with a total order of two bottles. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of that shelf life may have elapsed between the date of manufacture and the date of delivery to the government. Packaging must comply with commercial standards and meet the requirements of Medical Marking Standard No. 1, which supersedes MIL-STD-129; each unit must be sealed in a container that protects against damage, and all shipping containers must ensure safe, cost-effective delivery via common carrier to the designated destination. The product is regulated by the FDA and requires referral through EBS for confirmation by a product specialist, including full manufacturer and bidder details. Labeling, marking, and packaging must adhere strictly to the latest edition of Medical Marking Standard No. 1, accessible via the DLA website. Delivery is FOB destination within 20 days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505015056483, NDC 00536-1286-36, and is sourced from The Harvard Drug Group, L.L.C. under solicitation SPE2DP-26-T-4459, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with performance at Fort Drum, NY.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ARTIFICIAL TEARS SOLUT
Solicitation # SPE2DP-26-T-4455
The contract specifies the procurement of 20 packages of Artificial Tears Solution, each package containing 30 single-dose vials of 0.3 mL, for a total of 600 vials. The item is regulated by the FDA and has a non-extendable shelf life of 24 months, adhering to RS001 for TYPE I (CODE M) items. Packaging must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be hermetically sealed and protected against damage, packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost. The product, manufactured by Allergan Inc with NDC 00023-4554-30, must be labeled and marked per DLA specifications and is not considered hazardous under Fed-Std-313, requiring commercial packaging consistent with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Delivery is FOB destination within five days of order, with zero tolerance for quantity variance, and must be shipped by traceable means—parcel post is prohibited. The shipment is destined for USS THEODORE ROOSEVELT CVN 71, FPO AP 96632, with a required delivery date of August 5, 2026, and must include all applicable DLA packaging and labeling standards including palletization per RP001. The contracting official must submit an EBS referral for FDA confirmation, including manufacturer and product details.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 19 hours ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 541611
New
DIBBS
Small Business Subcontracting & Representation SupportThe contract seeks administrative and compliance support services focused on small business program representations, joint ventures, and certifications in alignment with Federal Acquisition Regulation and Department of Defense requirements. The work involves ensuring accurate and timely documentation and adherence to regulatory standards for small business classifications, subcontracting plans, and representation filings, with an emphasis on maintaining compliance across all phases of federal contracting processes. This support is critical for enabling eligible entities to properly declare and maintain their status under applicable small business programs and to facilitate valid joint venture arrangements. Performance will be centered in Gastonia, North Carolina, with a NAICS code of 541611 indicating management consulting services, suggesting a need for advisory and operational assistance rather than direct procurement or logistics. The solicitation was posted on August 3, 2026, with a response deadline of August 10, 2026, indicating a tight turnaround for proposals. Although no set-asides are specified, the nature of the services implies that eligibility and capability in navigating small business compliance frameworks will be central to evaluation. The contract falls under the Department of Defense, administered by the Medical Supply Chain Pharm FSA, requiring the contractor to work within the unique regulatory and procedural environment of military medical supply chain operations.
Administrative Management and General Management Consulting Services

POSTED

about 19 hours ago

DEADLINE

in 6 days
View Details